HUP0300813A2 - Gének, fehérjék és alkalmazásuk - Google Patents

Gének, fehérjék és alkalmazásuk

Info

Publication number
HUP0300813A2
HUP0300813A2 HU0300813A HUP0300813A HUP0300813A2 HU P0300813 A2 HUP0300813 A2 HU P0300813A2 HU 0300813 A HU0300813 A HU 0300813A HU P0300813 A HUP0300813 A HU P0300813A HU P0300813 A2 HUP0300813 A2 HU P0300813A2
Authority
HU
Hungary
Prior art keywords
peptides
nucleotide sequences
genes
proteins
microorganisms
Prior art date
Application number
HU0300813A
Other languages
English (en)
Inventor
Martin John Glenton Hughes
Jonathan Douglas Lane
Joseph David Tangelo
Original Assignee
Microscience Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microscience Limited filed Critical Microscience Limited
Publication of HUP0300813A2 publication Critical patent/HUP0300813A2/hu
Publication of HUP0300813A3 publication Critical patent/HUP0300813A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

A találmány baktériumok külső felszínén elhelyezkedő peptidekre és akódoló polinukleotidokra vonatkozik. A találmány tárgyát képeziktovábbá a peptideket kifejező gazdasejtek, valamint a peptideketkódoló nukleotidszekvenciákban mutációt hordozó mikroorganizmusok. Atalálmány a fenti nukleotidszekvenciák, peptidek és mikroorganizmusokterápiás alkalmazásra és gyógyszerkészítmények szkrínelésére valófelhasználására is vonatkozik. Ó
HU0300813A 2000-08-24 2001-08-21 Genes and proteins, and their uses HUP0300813A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0020952.8A GB0020952D0 (en) 2000-08-24 2000-08-24 Genes and proteins and their uses
PCT/GB2001/003759 WO2002016612A2 (en) 2000-08-24 2001-08-21 Genes and proteins, and their uses

Publications (2)

Publication Number Publication Date
HUP0300813A2 true HUP0300813A2 (hu) 2003-10-28
HUP0300813A3 HUP0300813A3 (en) 2007-10-29

Family

ID=9898283

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0300813A HUP0300813A3 (en) 2000-08-24 2001-08-21 Genes and proteins, and their uses

Country Status (13)

Country Link
US (1) US20040073000A1 (hu)
EP (1) EP1373511A2 (hu)
JP (1) JP2004507245A (hu)
KR (2) KR20080052693A (hu)
CN (1) CN1545552A (hu)
AU (2) AU2001282299B2 (hu)
CA (1) CA2420261A1 (hu)
GB (1) GB0020952D0 (hu)
HU (1) HUP0300813A3 (hu)
NO (1) NO20030821L (hu)
NZ (3) NZ548093A (hu)
RU (1) RU2313535C2 (hu)
WO (1) WO2002016612A2 (hu)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005064021A2 (en) * 2003-12-23 2005-07-14 Glaxosmithkline Biologicals S.A. Vaccine
US7709001B2 (en) 2005-04-08 2010-05-04 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
EP2425856A1 (en) 2005-04-08 2012-03-07 Wyeth LLC Multivalent pneumococcal polysaccharide-protein conjugate composition
US8261648B1 (en) 2011-10-17 2012-09-11 Sequent Medical Inc. Braiding mechanism and methods of use
CN116326547B (zh) * 2023-01-06 2023-11-10 广东省农业科学院植物保护研究所 一种针对荔枝蒂蛀虫幼虫室内毒力测定方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000022430A2 (en) * 1998-10-09 2000-04-20 Chiron Corporation Neisseria genomic sequences and methods of their use
DK1535928T3 (da) * 1998-10-22 2008-10-20 Univ Montana Vaccinesammensætninger indeholdende Omp85-proteiner af Neisseria gonorrhoeae og Neisseria meningitidis
PT2270173E (pt) * 1999-05-19 2016-03-28 Glaxosmithkline Biologicals Sa Composições de neisseria de combinação
US20050100892A1 (en) * 2002-07-22 2005-05-12 Shea Terrance P.Jr. Method of selecting genes for crop improvement

Also Published As

Publication number Publication date
JP2004507245A (ja) 2004-03-11
KR20030045039A (ko) 2003-06-09
HUP0300813A3 (en) 2007-10-29
AU8229901A (en) 2002-03-04
RU2313535C2 (ru) 2007-12-27
CN1545552A (zh) 2004-11-10
KR20080052693A (ko) 2008-06-11
NZ548093A (en) 2007-11-30
NZ524277A (en) 2005-09-30
CA2420261A1 (en) 2002-02-28
NO20030821D0 (no) 2003-02-21
GB0020952D0 (en) 2000-10-11
US20040073000A1 (en) 2004-04-15
NO20030821L (no) 2003-04-15
WO2002016612A2 (en) 2002-02-28
EP1373511A2 (en) 2004-01-02
NZ538864A (en) 2007-03-30
AU2001282299B2 (en) 2007-08-02
WO2002016612A3 (en) 2003-10-09

Similar Documents

Publication Publication Date Title
HUP0203409A2 (hu) Gamma-interferon-konjugátumok
DK0750672T3 (da) DNA-sekvenser for matrix-metalproteaser, deres tilvejebringelse og anvendelse
HUP0302481A2 (hu) Virulencia gének, fehérjék és alkalmazásuk
HUP0102302A2 (hu) Heliomicint kódoló gén és alkalmazása
AUPP472398A0 (en) Protease susceptibility II
ATE310085T1 (de) Cyclin-e2 proteine und dafür kodierende gene
HUP0300813A2 (hu) Gének, fehérjék és alkalmazásuk
AU2002214542A1 (en) Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
WO2001072977A3 (en) Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
WO2002042437A3 (en) Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
WO2002034922A3 (en) Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
WO2002000878A3 (fr) Dynamine mitochondriale humaine msp1, ses isoformes msp1-x, et leur utilisation en therapeutique
AU2001288363A1 (en) Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
EP1383907A4 (en) ISOLATED HUMAN PROTEASE PROTEINS, HUMAN PROTEASE PROTEINS CODING NUCLEIC ACID MOLECULES, AND USES THEREOF
HUP0004739A1 (hu) Presenilinekkel kölcsönhatásra képes fehérjéket kódoló nukleinsavak
WO2005049818A3 (en) Genes encoding human deubiquitinating enzymes
EP1383871A4 (en) INSULATED HUMAN ENZYMATIC PROTEINS, NUCLEIC ACID MOLECULES ENCODING THESE PROTEINS, AND USES THEREOF
AU2002229060A1 (en) Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
EP1385991A4 (en) HUMAN INSULATED ENZYMATIC PROTEINS, NUCLEIC ACID MOLECULES ENCODING THE SAME AND USES THEREOF
EP1383877A4 (en) INSULATED HUMAN ENZYMATIC PROTEINS, NUCLEIC ACID MOLECULES ENCODING HUMAN ENZYMATIC PROTEINS, AND USES THEREOF
EP1383908A4 (en) ISOLATED HUMAN ENZYME PROTEINS, HUMAN ENZYME PROTEIN CODING NUCLEIC ACID MOLECULES, AND USES THEREOF
EP1379678A4 (en) HUMAN PROTEASE ISOLATED PROTEINS, NUCLEIC ACID MOLECULES ENCODING HUMAN PROTEASE PROTEINS AND USES THEREOF
EP1395674A4 (en) ISOLATED HUMAN PROTEASE PROTEINS, HUMAN PROTEASE PROTEIN CODING NUCLEIC ACID MOLECULES AND USES THEREOF
EP1383876A4 (en) ISOLATED HUMAN ENZYME PROTEINS, HUMAN ENZYME PROTEIN CODING NUCLEIC ACID MOLECULES, AND USES THEREOF
AU2003217864A8 (en) Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees